Autolus Therapeutics's total assets for Q4 2025 were $589.07M, a decrease of -11.01% from the previous quarter. AUTL total liabilities were $410.94M for the fiscal quarter, a 3.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.